Heghine Khachatryan: World Federation of Hemophilia Is Far More Than An Organization
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from WFH on LinkedIn:
”WFH’s work consistently reinforces a critical truth:
bleeding disorders are not only medical conditions — they are issues of health equity, gender equity, and human rights.
-For clinicians, WFH represents knowledge, standards, and professional growth
-For patients, it provides voice, visibility, and dignity
– For health systems, it offers a sustainable model for organizing rare disease care.
World Federation of Hemophilia (WFH) is far more than an organization — it is a global movement that has fundamentally transformed the lives of people living with hemophilia and other inherited bleeding disorders worldwide.
As 2025 comes to a close, WFH’s impact is particularly evident in several key areas:
• increasing global awareness of hemophilia and bleeding disorders,
• addressing the long-standing underdiagnosis of bleeding disorders in women and girls,
• strengthening continuous medical education for healthcare professionals,
• advancing laboratory standards, clinical guidelines, and evidence-based care, and
• expanding equitable access to safe and effective treatment.
With gratitude for WFH’s global leadership, collaboration, and unwavering commitment to patient-centered care.”
Qutoing World Federation of Hemophilia‘s post:
”As 2025 comes to a close, the World Federation of Hemophilia is celebrating a year of meaningful progress for people with hemophilia and Bleeding Disorders around the world.
Thanks to our global community, partners, and volunteers, this year saw important milestones, from expanding diagnosis and care to strengthening humanitarian aid and advancing treatment standards.
Read more.
Wishing our community a bright start to 2026, we look forward to connecting with you in Malaysia for the WFH 2026 World Congress!”
Stay updated with Hemostasis Today.
-
Dec 21, 2025, 08:12The Role of Viscoelastic Testing in Assessing Hemostasis: A Challenge to Standard Laboratory Assays?
-
Dec 21, 2025, 07:21Arsene Mekinian Announces New Expert Clinic for Refractory Hemato-Immunologic Diseases
-
Dec 21, 2025, 07:11Robrecht Knapen on Optimzing Recanalization in Acute Ischemic Stroke Patients
-
Dec 21, 2025, 06:54Afshin Moradi on TSH Level and Stroke Severity
-
Dec 21, 2025, 06:41Architha Reddy on Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
-
Dec 21, 2025, 06:28Siddarth Raajasekar on Neopterin Association with Stroke and Carotid Endarterectomy
-
Dec 20, 2025, 23:44Alen Emmanuel Joshy: CT Brain in Intracranial Hemorrhage
-
Dec 20, 2025, 23:37CSL Champions Global Equity in Rare Disease Diagnosis and Treatment
-
Dec 20, 2025, 23:22New Article by Mauricio Wajngarten Extended Anticoagulation After Unprovoked VTE